Interestingly, Porcu M et al. (2012) reported that T-ALL patients and T-cell lines harboring inactivating mutations in the PTPRC gene (which encodes the CD54 phosphatase) and activating mutations in the JAK1 or IL7R genes exhibit an increased JAK/STAT signaling. The gene discussed is PTPRC; the disease is acute lymphoblastic leukemia.